Skip to main content
Premium Trial:

Request an Annual Quote

Mammoth Biosciences: Peter Nell, Ted Tisch

Mammoth Biosciences has appointed Peter Nell as chief business officer and head of therapeutics, and has named Ted Tisch chief operations officer.

Nell has previously served in various positions at Casebia Therapeutics and Bayer HealthCare. In his new role at Mammoth, he will scale the company's CRISPR offerings. Nell is a chemist by training, and is listed as co-inventor on more than 45 patents, and author or co-author of several scientific publications and book contributions in the biomedical field. 

Tisch joins Mammoth after four years at Synthego, where he established the product development, manufacturing operations, and commercial program for two CRISPR-based product lines. He previously served as vice president and general manager for Bio-Rad Laboratories' protein function division.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.